In line with these notions that SMAD1 functioned as oncogene involving in promotion of cancer cell growth and invasion, we have unambiguously demonstrated that expression of SMAD1 was significantly suppressed in response to baohuoside-I treatment, which exclusively depended on miR-144 up-regulation. Here, SMAD1 is linked to cancer.